These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 10208939)

  • 61. N-Terminal extension of human immunodeficiency virus capsid protein converts the in vitro assembly phenotype from tubular to spherical particles.
    Gross I; Hohenberg H; Huckhagel C; Kräusslich HG
    J Virol; 1998 Jun; 72(6):4798-810. PubMed ID: 9573245
    [TBL] [Abstract][Full Text] [Related]  

  • 62. SUN1 Regulates HIV-1 Nuclear Import in a Manner Dependent on the Interaction between the Viral Capsid and Cellular Cyclophilin A.
    Luo X; Yang W; Gao G
    J Virol; 2018 Jul; 92(13):. PubMed ID: 29643244
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Cyclophilin binding to the human immunodeficiency virus type 1 Gag polyprotein is mimicked by an anti-cyclosporine antibody.
    Franke EK; Chen BX; Tatsis I; Diamanduros A; Erlanger BF; Luban J
    J Virol; 1995 Sep; 69(9):5821-3. PubMed ID: 7543589
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Structural insights into the stabilization of the human immunodeficiency virus type 1 capsid protein by the cyclophilin-binding domain and implications on the virus cycle.
    Cortines JR; Lima LM; Mohana-Borges R; Millen Tde A; Gaspar LP; Lanman JK; Prevelige PE; Silva JL
    Biochim Biophys Acta; 2015 May; 1854(5):341-8. PubMed ID: 25526889
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A Tripartite Complex HIV-1 Tat-Cyclophilin A-Capsid Protein Enables Tat Encapsidation That Is Required for HIV-1 Infectivity.
    Schatz M; Marty L; Ounadjela C; Tong PBV; Cardace I; Mettling C; Milhiet PE; Costa L; Godefroy C; Pugnière M; Guichou JF; Mesnard JM; Blaise M; Beaumelle B
    J Virol; 2023 Apr; 97(4):e0027823. PubMed ID: 37129415
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Cyclophilin A modulates the sensitivity of HIV-1 to host restriction factors.
    Towers GJ; Hatziioannou T; Cowan S; Goff SP; Luban J; Bieniasz PD
    Nat Med; 2003 Sep; 9(9):1138-43. PubMed ID: 12897779
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Human immunodeficiency virus type 1 Gag protein binds to cyclophilins A and B.
    Luban J; Bossolt KL; Franke EK; Kalpana GV; Goff SP
    Cell; 1993 Jun; 73(6):1067-78. PubMed ID: 8513493
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Virus particle core defects caused by mutations in the human immunodeficiency virus capsid N-terminal domain.
    Scholz I; Arvidson B; Huseby D; Barklis E
    J Virol; 2005 Feb; 79(3):1470-9. PubMed ID: 15650173
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Cyclophilin A-dependent restriction of human immunodeficiency virus type 1 capsid mutants for infection of nondividing cells.
    Qi M; Yang R; Aiken C
    J Virol; 2008 Dec; 82(24):12001-8. PubMed ID: 18829762
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Cyclophilin A promotes HIV-1 reverse transcription but its effect on transduction correlates best with its effect on nuclear entry of viral cDNA.
    De Iaco A; Luban J
    Retrovirology; 2014 Jan; 11():11. PubMed ID: 24479545
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Cyclophilin A interacts with diverse lentiviral capsids.
    Lin TY; Emerman M
    Retrovirology; 2006 Oct; 3():70. PubMed ID: 17038183
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Inhibition of HIV-1 Maturation via Small-Molecule Targeting of the Amino-Terminal Domain in the Viral Capsid Protein.
    Wang W; Zhou J; Halambage UD; Jurado KA; Jamin AV; Wang Y; Engelman AN; Aiken C
    J Virol; 2017 May; 91(9):. PubMed ID: 28202766
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Human immunodeficiency virus type 1 hijacks host cyclophilin A for its attachment to target cells.
    Saphire AC; Bobardt MD; Gallay PA
    Immunol Res; 2000; 21(2-3):211-7. PubMed ID: 10852119
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Cyclophilin A stabilizes the HIV-1 capsid through a novel non-canonical binding site.
    Liu C; Perilla JR; Ning J; Lu M; Hou G; Ramalho R; Himes BA; Zhao G; Bedwell GJ; Byeon IJ; Ahn J; Gronenborn AM; Prevelige PE; Rousso I; Aiken C; Polenova T; Schulten K; Zhang P
    Nat Commun; 2016 Mar; 7():10714. PubMed ID: 26940118
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Electron cryotomography studies of maturing HIV-1 particles reveal the assembly pathway of the viral core.
    Woodward CL; Cheng SN; Jensen GJ
    J Virol; 2015 Jan; 89(2):1267-77. PubMed ID: 25392219
    [TBL] [Abstract][Full Text] [Related]  

  • 76. CA Mutation N57A Has Distinct Strain-Specific HIV-1 Capsid Uncoating and Infectivity Phenotypes.
    Fischer DK; Saito A; Kline C; Cohen R; Watkins SC; Yamashita M; Ambrose Z
    J Virol; 2019 May; 93(9):. PubMed ID: 30814280
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Cyclophilin A levels dictate infection efficiency of human immunodeficiency virus type 1 capsid escape mutants A92E and G94D.
    Ylinen LM; Schaller T; Price A; Fletcher AJ; Noursadeghi M; James LC; Towers GJ
    J Virol; 2009 Feb; 83(4):2044-7. PubMed ID: 19073742
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Phosphorylation of human immunodeficiency virus type 1 capsid protein at serine 16, required for peptidyl-prolyl isomerase-dependent uncoating, is mediated by virion-incorporated extracellular signal-regulated kinase 2.
    Dochi T; Nakano T; Inoue M; Takamune N; Shoji S; Sano K; Misumi S
    J Gen Virol; 2014 May; 95(Pt 5):1156-1166. PubMed ID: 24509437
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Strain-specific differences in the impact of human TRIM5alpha, different TRIM5alpha alleles, and the inhibition of capsid-cyclophilin A interactions on the infectivity of HIV-1.
    Battivelli E; Lecossier D; Matsuoka S; Migraine J; Clavel F; Hance AJ
    J Virol; 2010 Nov; 84(21):11010-9. PubMed ID: 20702630
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Multiple Roles of HIV-1 Capsid during the Virus Replication Cycle.
    Novikova M; Zhang Y; Freed EO; Peng K
    Virol Sin; 2019 Apr; 34(2):119-134. PubMed ID: 31028522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.